NASDAQ 0001850266 0001850266 2022-12-23 2022-12-23

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K/A

(Amendment No. 1)

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):

December 27, 2022 (December 23, 2022)

 

 

Akili, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40558   98-1586159

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

125 Broad Street, Fifth Floor,
 
Boston MA   02110
(Address of Principal Executive Offices)   (Zip Code)

(617) 456-0597

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common stock, par value $0.0001 per share   AKLI   Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


EXPLANATORY NOTE

This Amendment No. 1 on Form 8-K/A (this “Form 8-K/A”) is an amendment to the Current Report on Form 8-K of Akili, Inc., filed on December 23, 2022 (the “Original Form 8-K”). The Original Form 8-K was inadvertently filed prematurely by Akili, Inc.’s service provider and this Form 8-K/A is being filed to correct that error.

 

Item 1.01

Entry into a Material Definitive Agreement.

On December 23, 2022, Akili, Inc., a Delaware corporation (the “Company”), and its wholly-owned subsidiary, Akili Interactive Labs, Inc., a Delaware corporation (the “Existing Borrower”) (the Company and the Existing Borrower collectively, the “Borrower”), entered into a Joinder and First Loan Modification Agreement (the “Loan Modification Agreement”) between the Borrower and Silicon Valley Bank, in its capacity as administrative agent and collateral agent (the “Agent”), and Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P., as lenders (the “Lenders”). The Loan Modification Agreement modifies certain sections of the Amended and Restated Loan and Security Agreement dated as of May 25, 2021, among the Borrower, the Lenders and the Agent (the “Original Loan Agreement”).

The Loan Modification Agreement joins the Company to the Original Loan Agreement as a borrower. The Loan Modification Agreement also amends the Original Loan Agreement to decrease the Lenders’ Term A Loan Advance (as defined in the Original Loan Agreement) commitment from an original principal amount of up to $35,000,000 to an original principal amount of up to $25,000,000 while extending the expiration of the Term A Loan Draw Period (as defined in the Original Loan Agreement) to March 31, 2023, and to increase the Lenders’ Term C Loan Advance (as defined in the Original Loan Agreement) commitment from an original principal amount of up to $10,000,000 to an original principal amount of up to $20,000,000 while extending the expiration of the Term C Loan Draw Period (as defined in the Original Loan Agreement) to May 31, 2023. As of September 30, 2022, there was $15.0 million outstanding pursuant to the terms of the Original Loan Agreement.

The foregoing description of the Loan Modification Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Loan Modification Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in response to Item 1.01 of this Current Report on Form 8-K above regarding the Loan Modification Agreement is incorporated by reference in response to this Item 2.03 of this Current Report on Form 8-K.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

 

No.

   Description of Exhibit
10.1    Joinder and First Loan Modification Agreement, dated December 23, 2022, by and among Silicon Valley Bank, in its capacity as administrative agent and collateral agent, Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P., as lenders, and Akili, Inc. and Akili Interactive Labs, Inc., as borrowers.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Akili, Inc.
By:  

/s/ Santosh Shanbhag

Name:   Santosh Shanbhag
Title:   Chief Financial Officer

Date: December 27, 2022